Fresenius Medical Care stock at EUR 40.44 on September 28, 2026
Published on 09/28/2026 at 22:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Fresenius Medical Care stock last traded at EUR 40.44 on Xetra at 14:25 on September 28, 2026, up 1.14 percent from the previous session.
Trading session
The security is listed on the Frankfurt Stock Exchange under ticker FME. The reported Xetra quote refers to the regular trading session on September 28, 2026.
China portfolio changes
In a September 25, 2026 release, Fresenius Medical Care said it would exit its China peritoneal dialysis business and discontinue local production and sales of the 4008A hemodialysis system while maintaining existing obligations. The company said it will focus more on in-center dialysis and critical-care technologies, including the 5008S CAREsystem and multiFiltratePRO.
The portfolio actions are expected to result in approximately EUR 110 million in one-time costs, mainly related to impairment charges, scrappage and termination costs. The company said the charge is expected to be recognized as a special item in the third quarter of 2026 and that the portfolio adjustment is not expected to meaningfully affect the future revenue outlook for its Care Enablement business in China.
